12/30/2024
6:41 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
6:44 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
6:45 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
6:47 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
4:04 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
4:02 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
4:03 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
4:04 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
4:05 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
4:04 PM | Cumberland Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
4:09 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/06/2024
4:12 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
3:38 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:39 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:39 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:15 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:06 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:07 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:08 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
10:31 AM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
9:42 AM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
5:29 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:40 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:42 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
4:07 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
4:33 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:31 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:32 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:32 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
3:37 PM | Cumberland Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
4:14 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
7:22 PM | Cumberland Pharmaceuticals (Issuer)
Hamm John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:24 PM | Anthony Todd M. (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:25 PM | Bitterman Chris T. (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:26 PM | Cumberland Pharmaceuticals (Issuer)
Herman James L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:28 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:29 PM | Brown Martin S JR (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:31 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:31 PM | Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:32 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:33 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Is Starlink Set For The Largest IPO In History? (Ad) He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant.
Then, he did it again with Tesla… which is up more than 19,500% since 2010.
For perspective, that turns $100 invested into almost $20,000! Click here now for the urgent details. |
03/20/2024
4:15 PM | Cumberland Pharmaceuticals (Filer)
| Form 424B5 | |
03/20/2024
4:20 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:03 PM | Cumberland Pharmaceuticals (Filer)
| Form DEF 14A | |
03/13/2024
4:04 PM | Cumberland Pharmaceuticals (Filer)
| Form DEFA14A | |
03/05/2024
4:10 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
4:27 PM | Cumberland Pharmaceuticals (Subject)
| Form SC 13G | |
